Upstream Bio, Profitability Analysis
| UPB Stock | 17.12 2.07 10.79% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -20.5 M | Current Value -21.6 M | Quarterly Volatility 1 M |
For Upstream Bio, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Upstream Bio, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Upstream Bio, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Upstream Bio,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Upstream Bio, over time as well as its relative position and ranking within its peers.
Upstream |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio,. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Upstream Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Upstream Bio, is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio,'s market value can be influenced by many factors that don't directly affect Upstream Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Upstream Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Upstream Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
UPB fundamentals not found
We are unable to locate Upstream Bio, indicator at this time.
If you believe the indicator you are trying to look up is valid, please let us know, and we will check it out. Check all delisted instruments across multiple markets.| Symbol | UPB |
| Name | Upstream Bio, |
| Type | Stock |
| Country | United States |
| Exchange | NASDAQ |
Indicator Description
We cannot locate any information for this view at this time. Please try again later!Other Suggestions
| U | Unity Software | Company |
| USB-PS | US Bancorp | Company |
| USA | Liberty All Star | Fund |
| UK | Ucommune International | ETF |
| UTY | PHLX Utility | Index |
| UQC | Uquid Coin | Cryptocurrency |
| U12501BH1 | CHTR 425 01 FEB 31 | Corporate Bond |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
| NU | Nu Holdings | |
| IBM | International Business Machines | |
| IRS | IRSA Inversiones Y | |
| QFIN | 360 Finance | |
| GOOG | Alphabet Inc Class C |
Upstream Bio, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Upstream Bio,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Upstream Bio, will eventually generate negative long term returns. The profitability progress is the general direction of Upstream Bio,'s change in net profit over the period of time. It can combine multiple indicators of Upstream Bio,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 4.2 M | 2.4 M | |
| Interest Income | 4.2 M | 2.4 M | |
| Operating Income | -40.1 M | -42.1 M | |
| Net Loss | -20.5 M | -21.6 M | |
| Income Before Tax | -20.5 M | -21.6 M | |
| Total Other Income Expense Net | 15.4 M | 8.4 M | |
| Net Loss | -20.5 M | -21.6 M |
Upstream Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Upstream Bio,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Upstream Bio, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Upstream Bio,'s important profitability drivers and their relationship over time.
Upstream Bio, Profitability Trends
Upstream Bio, profitability trend refers to the progression of profit or loss within a business. An upward trend means that Upstream Bio,'s profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Upstream Bio,'s gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.
Upstream Bio, Profitability Drivers Correlations
One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Upstream Bio, different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Upstream Bio, in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Upstream Bio,'s future profitability.
Click cells to compare fundamentals
Use Upstream Bio, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Upstream Bio, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Upstream Bio, will appreciate offsetting losses from the drop in the long position's value.Upstream Bio, Pair Trading
Upstream Bio, Pair Trading Analysis
The ability to find closely correlated positions to Upstream Bio, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Upstream Bio, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Upstream Bio, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Upstream Bio, to buy it.
The correlation of Upstream Bio, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Upstream Bio, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Upstream Bio, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Upstream Bio, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Upstream Bio, position
In addition to having Upstream Bio, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gambling Thematic Idea Now
Gambling
Companies that are related to providing gambling services across multiple geographical areas by investing, exploring, or producing software, hardware, and related infrastructure for running gambling operations or trading speculative assets. The Gambling theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gambling Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
To fully project Upstream Bio,'s future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Upstream Bio, at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Upstream Bio,'s income statement, its balance sheet, and the statement of cash flows.